We are live on ! Find out more
ICM

ISZO Capital Management Portfolio holdings

AUM $2M
1-Year Est. Return 35.61%
This Fund
S&P 500
This Quarter Est. Return
+23.94%
1 Year Est. Return
+35.61%
3 Year Est. Return
+68.24%
5 Year Est. Return
+471.73%
10 Year Est. Return
–
AUM
$193M
AUM Growth
+$26.7M
Cap. Flow
-$8.07M
Cap. Flow %
-4.19%
Top 10 Hldgs %
99.66%
Holding
19
New
4
Increased
3
Reduced
3
Closed
5

Top Buys

Rank Stock Value
1
UHAL icon
U-Haul Holding Co
UHAL
+$2.99M
2
NVGS icon
Navigator Holdings
NVGS
+$1.46M
3
IIN
IntriCon Corporation
IIN
+$1.08M
4
STRP
Straight Path Communications Inc.
STRP
+$675K
5
APEX
Apex Global Brands Inc. Common Stock
APEX
+$625K

Top Sells

Rank Stock Value
1
HRTX icon
Heron Therapeutics
HRTX
+$4.83M
2
ARQ icon
Arq
ARQ
+$3.24M
3
INSY
Insys Therapeutics, Inc.
INSY
+$2.78M
4
GLDD
Great Lakes Dredge & Dock
GLDD
+$2.71M
5
XRM
Xerium Technologies Inc (new)
XRM
+$1.4M

Sector Composition

Rank Sector Weight
1 Healthcare 83.75%
2 Industrials 7.35%
3 Energy 5.04%
4 Technology 0.72%
5 Consumer Discretionary 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TARO
1
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$155M 80.27%
1,104,168
-40
-0% -$4.44K
UHAL icon
2
U-Haul Holding Co
UHAL
$13.9B
$14.2M 7.35%
487,860
+113,000
+30% +$2.99M
NVGS icon
3
Navigator Holdings
NVGS
$1.38B
$9.73M 5.04%
331,100
+55,300
+20% +$1.46M
ASRT
4
DELISTED
Assertio
ASRT
$3.88M 2.01%
4,652
-277
-6% -$213K
AMBC.WS
5
DELISTED
Ambac Financial Group
AMBC.WS
$3.42M 1.77%
203,819
+8,700
+4% +$166K
AIQ
6
DELISTED
Alliance Healthcare Services
AIQ
$2.84M 1.47%
105,222
-4,200
-4% -$124K
IIN
7
DELISTED
IntriCon Corporation
IIN
$1.38M 0.72%
+161,083
New +$1.08M
STRP
8
DELISTED
Straight Path Communications Inc.
STRP
$832K 0.43%
+81,600
New +$675K
APEX
9
DELISTED
Apex Global Brands Inc. Common Stock
APEX
$681K 0.35%
+1,493
New +$625K
CVA
10
DELISTED
Covanta Holding Corporation
CVA
$467K 0.24%
22,657
– –
UCB
11
United Community Banks
UCB
$4.24B
$245K 0.13%
14,944
– –
BBW icon
12
Build-A-Bear
BBW
$425M
$233K 0.12%
+17,445
New +$228K
RITM icon
13
Rithm Capital
RITM
$5.52B
$96K 0.05%
7,637
– –
DS
14
DELISTED
Drive Shack Inc.
DS
$73K 0.04%
14,192
– –
GLDD
15
DELISTED
Great Lakes Dredge & Dock
GLDD
– –
-297,300
Closed -$2.71M
HRTX icon
16
Heron Therapeutics
HRTX
$93.9M
– –
-347,051
Closed -$4.83M
ARQ icon
17
Arq
ARQ
$84.6M
– –
-132,006
Closed -$3.24M
INSY
18
DELISTED
Insys Therapeutics, Inc.
INSY
– –
-134,094
Closed -$2.78M
XRM
19
DELISTED
Xerium Technologies Inc (new)
XRM
– –
-87,257
Closed -$1.4M

Similar funds

LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

ISZO Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, ISZO Capital Management held 19 positions worth $193M, up 16% from $166M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ISZO Capital Management withdrew a net $8.07M in Q2 2014, closing 5 positions and reducing 3 holdings. Its most notable exit was Heron Therapeutics, an estimated $4.83M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 83% a quarter earlier, followed by Industrials and Energy.

Against the trend, ISZO Capital Management opened a new position in IntriCon Corporation worth $1.38M.

  • ISZO Capital Management's largest Q2 2014 buy was IntriCon Corporation: 161,083 shares worth $1.38M.
  • ISZO Capital Management added most to U-Haul Holding Co in Q2 2014, an estimated $2.99M increase.
  • ISZO Capital Management's biggest Q2 2014 reduction was Assertio, cutting an estimated $213K.
  • ISZO Capital Management fully exited Heron Therapeutics in Q2 2014, selling an estimated $4.83M.
  • ISZO Capital Management's ten largest holdings make up 100% of its $193M portfolio in Q2 2014.
  • ISZO Capital Management opened 4 new positions and closed 5 in Q2 2014.
  • ISZO Capital Management's portfolio value rose 16% quarter-over-quarter to $193M.

Based on ISZO Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.